No profile data available.
ClearPoint Neuro, Inc. (CLPT) is a healthcare company in the targeted healthcare equipment industry, based in Solana Beach, United States, with about 160 full-time employees.
It reported revenue of $36.97 million for fiscal year 2025, up 17.8% from fiscal year 2024, and net income of -$25.54 million. Its market capitalization was $332.34 million as of October 2, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 2, 2026.
, a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
ClearPoint Neuro reported $36.97 million in revenue for fiscal year 2025, up 17.8% from $31.39 million in fiscal year 2024.
$332.34 million as of October 2, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include BrainsWay Ltd. (BWAY), NeuroPace, Inc. (NPCE), CapsoVision, Inc. (CV), Humacyte, Inc. (HUMA).